Status:
COMPLETED
Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers
Lead Sponsor:
Vantive Health LLC
Collaborating Sponsors:
Gambro Renal Products, Inc.
Baxter Healthcare Corporation
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Polyflux HD-C4 (Gambro Renal Products) is a new dialyzer based on the existing Polyflux H membrane and dialyzer technology, but which achieves a performance comparable to Polyflux 210H in a signif...
Eligibility Criteria
Inclusion
- Adults 18 years of age or older
- Stable hemodialysis prescription using Polyflux 210H or Polyflux 21R for at least 2 months prior to study enrollment
- Dialyzing through a native fistula or Gore-Tex graft.
- Blood access must be able to provide a blood flow rate of 400 ml/min.
Exclusion
- Non-compliance with dialysis
- Hematocrit less than 28%
- Active Infection
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00636389
Start Date
February 1 2008
End Date
March 1 2009
Last Update
July 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DaVita Clinical Research Facility
Minneapolis, Minnesota, United States, 55404